These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30711624)

  • 1. α-Methyl-prednisolone normalizes the PKC mediated brain angiogenesis in dystrophic mdx mice.
    Annese T; Ruggieri S; De Giorgis M; Ribatti D; Tamma R; Nico B
    Brain Res Bull; 2019 Apr; 147():69-77. PubMed ID: 30711624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouse.
    Nico B; Mangieri D; Crivellato E; Longo V; De Giorgis M; Capobianco C; Corsi P; Benagiano V; Roncali L; Ribatti D
    Brain Pathol; 2007 Oct; 17(4):399-406. PubMed ID: 17784876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.
    Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B
    Lab Invest; 2013 May; 93(5):592-610. PubMed ID: 23528847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
    Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
    Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
    Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
    Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.
    Nico B; Corsi P; Ria R; Crivellato E; Vacca A; Roccaro AM; Mangieri D; Ribatti D; Roncali L
    Neuroscience; 2006 Jul; 140(3):835-48. PubMed ID: 16650610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.
    Cozzoli A; Rolland JF; Capogrosso RF; Sblendorio VT; Longo V; Simonetti S; Nico B; De Luca A
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):243-56. PubMed ID: 20618838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse.
    Nico B; Mangieri D; De Luca A; Corsi P; Benagiano V; Tamma R; Annese T; Longo V; Crivellato E; Ribatti D
    Neuroscience; 2009 Jul; 161(4):1057-66. PubMed ID: 19376199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photobiomodulation Therapy for Attenuating the Dystrophic Phenotype of Mdx Mice.
    Macedo AB; Mizobuti DS; Hermes TA; Mâncio RD; Pertille A; Kido LA; Cagnon VHA; Minatel E
    Photochem Photobiol; 2020 Jan; 96(1):200-207. PubMed ID: 31733143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy.
    Mantuano P; Sanarica F; Conte E; Morgese MG; Capogrosso RF; Cozzoli A; Fonzino A; Quaranta A; Rolland JF; De Bellis M; Camerino GM; Trabace L; De Luca A
    Biochem Pharmacol; 2018 Aug; 154():89-103. PubMed ID: 29684379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier alterations in MDX mouse, an animal model of the Duchenne muscular dystrophy.
    Nico B; Roncali L; Mangieri D; Ribatti D
    Curr Neurovasc Res; 2005 Jan; 2(1):47-54. PubMed ID: 16181099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy.
    Nico B; Marzullo A; Corsi P; Vacca A; Roncali L; Ribatti D
    Neuroscience; 2004; 123(3):585-8. PubMed ID: 14706770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of increased S100β and Tau5 proteins in dystrophic nerves of two mdx mouse models for Duchenne muscular dystrophy.
    Krishnan VS; Aartsma-Rus A; Overzier M; Lutz C; Bogdanik L; Grounds MD
    Mol Cell Neurosci; 2020 Jun; 105():103484. PubMed ID: 32240725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain.
    Nico B; Corsi P; Vacca A; Roncali L; Ribatti D
    Brain Res; 2002 Oct; 953(1-2):12-6. PubMed ID: 12384233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes.
    Weller C; Zschüntzsch J; Makosch G; Metselaar JM; Klinker F; Klinge L; Liebetanz D; Schmidt J
    J Neurosci Res; 2012 May; 90(5):1067-77. PubMed ID: 22253213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.